Clinical Trials Browser

Completed × OTHER × Neoplasm Metastasis × Clear all

NCT03725436 2026-03-16

ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors

Phase 1 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT00905047 2026-03-13

COLOCROSS

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT01606033 2026-03-13

IPSY

Phase NA Completed

Other hematologic neoplasm

Neoplasm Metastasis, Hematologic Neoplasms

NCT01900743 2026-03-13

REGO-SARC

Phase 2 Completed

Neoplasm Metastasis, Sarcoma

NCT05209880 2026-03-13

Advance Care Planning in the Emergency Department

Phase NA Completed

141 enrolled 15 charts

Heart Failure, Neoplasm Metastasis, Pulmonary Disease, Chronic Obstructive

NCT04308356 2026-03-11

ESOP

Neoplasm Metastasis

NCT05665348 2026-03-09

TRIPLET

Phase 2/3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasm Metastasis

NCT01560416 2026-03-03

Fulvestrant With or Without Ganetespib in HR+ Breast Cancer

Phase 2 Completed

50 enrolled 14 charts

Breast Neoplasms, Neoplasm Metastasis

NCT05564468 2026-02-27

Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning in Patients With Advanced Cancer

Phase NA Completed

Neoplasm Metastasis

NCT04233567 2026-02-24

Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations

Phase 2 Completed

17 enrolled 12 charts

Gastrointestinal

Neoplasm Metastasis, Cholangiocarcinoma

NCT01659151 2026-02-20

Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma

Phase 2 Completed

17 enrolled 11 charts

Melanoma, Neoplasm Metastasis

NCT03388190 2026-02-13

METIMMOX

Phase 2 Completed

80 enrolled 13 charts

Neoplasm Metastasis, Neoplasms

NCT03942497 2026-02-12

Clinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin America

Neoplasm Metastasis, Recurrence

NCT03993353 2026-02-12

Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

7 enrolled 14 charts

GastrointestinalHead & Neck

Pyridoxine-dependent epilepsy, Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Esophageal Neoplasms, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms

NCT03775980 2026-02-11

CIEMAR

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis

NCT02964078 2026-02-10

Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer

Phase 2 Completed

27 enrolled 10 charts

Kidney Diseases, Kidney Neoplasms, Neoplasm Metastasis

NCT05648240 2026-02-10

EARDIS

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT06379880 2026-02-04

FEGALA

Phase NA Completed

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms, Colorectal Neoplasms

NCT07386639 2026-02-04

GENDER-HCC-MET

19,019 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis

NCT03082534 2026-01-28

Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Recurrence

NCT05276284 2026-01-14

TEMPLE

Phase 1/2 Completed

Neoplasm Metastasis

NCT02069730 2026-01-08

A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes

Phase NA Completed

Neoplasm Metastasis, Neoplasms, Recurrence, Salivary Gland Neoplasms

NCT04326257 2026-01-08

Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy

Phase 2 Completed

20 enrolled 13 charts

Diabetes Mellitus, Insulin-Dependent, 12, Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT02314364 2025-12-16

A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC

Phase 2 Completed

27 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT04330833 2025-12-08

IMPACT

Phase NA Completed

Communication, Death, Neoplasm Metastasis

NCT04021043 2025-12-03

BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers

Phase 1/2 Completed

51 enrolled 16 charts

Neoplasm Metastasis

NCT02639026 2025-11-25

Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers

Phase 1 Completed

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms

NCT01771458 2025-11-24

SHIVA

Phase 2 Completed

Neoplasm Metastasis

NCT04778631 2025-11-20

PERISAFE

Phase NA Completed

Hyperthermia, Agnosia, Neoplasm Metastasis, Pelvic Pain, Acute Pain

NCT05472532 2025-11-20

INOVOLINE

Phase NA Completed

BreastGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms

NCT05052723 2025-11-19

Cabozantinib and Pembrolizumab in Metastatic Pancreas

Phase 2 Completed

21 enrolled 12 charts

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms

NCT02812667 2025-11-12

Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

NCT05847686 2025-11-05

Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer

Phase 1/2 Completed

55 enrolled 11 charts

Neoplasm Metastasis

NCT01582191 2025-10-27

Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer

Phase 1 Completed

Neoplasm Metastasis, Neoplasms, Recurrence

NCT04010240 2025-10-16

NTRK

3,820 enrolled 3 charts

Neoplasm Metastasis

NCT06644170 2025-10-14

A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic Cancer

Phase 1 Completed

Neoplasm Metastasis

NCT03652493 2025-10-06

PRO-CARBO

Phase 2 Completed

Neoplasm Metastasis

NCT04263948 2025-10-03

MULTIDOM

Phase NA Completed

Gastrointestinal

Motor Activity, Neoplasm Metastasis, Pancreatic Neoplasms, Patient Compliance

NCT06296056 2025-10-01

SDH-Combi

Phase 1 Completed

Neoplasm Metastasis

NCT03711058 2025-09-16

Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer

Phase 1/2 Completed

48 enrolled 16 charts

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Spinocerebellar Degenerations

NCT06504719 2025-09-15

Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis

NCT03098836 2025-09-12

PANTHER

Phase 2 Completed

93 enrolled 17 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT04530513 2025-09-12

ARREST - A Phase I Study of SABR for Poly-metastatic Disease

Phase NA Completed

Neoplasm Metastasis

NCT04889144 2025-09-09

PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning

Phase NA Completed

27 enrolled 11 charts

Communication, Neoplasm Metastasis

NCT06648161 2025-09-09

Using a Mirror in the Second Stage of Labor: Effects on Duration and Birth Experience

Phase NA Completed

122 enrolled 9 charts

Neoplasm Metastasis

NCT03977818 2025-09-05

METASARC

2,165 enrolled 4 charts

Neoplasm Metastasis, Sarcoma

NCT00712712 2025-08-29

MEDOR

Phase 2 Completed

78 enrolled 28 charts

Neoplasm Metastasis, Pain

NCT07111104 2025-08-08

ARIS

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT02775292 2025-07-30

NYM

Phase 1 Completed

Neoplasm Metastasis

NCT04300790 2025-07-29

METALLICA

Phase 2 Completed

BreastEndocrine

Breast Neoplasms, Hyperglycemia, Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1